CTCF and Dravet syndrome: Finally, CCCTC-binding factor (CTCF) is a tumor suppressor and involved in many cellular processes, with approximately 11.3–20.4% of ML-DS cases harboring CTCF gene mutations (Yoshida et al., 2013; Labuhn et al., 2019; Panferova et al., 2021).